Studies showed that PTHrP levels were much higher in primary tumours of breast cancer patients who later developed bone metastasis [6]–[8], thus leading to the hypothesis that PTHrP expression in primary breast tumours increases the probability of bone metastasis and decreased patient survival. The gene discussed is PTHLH; the disease is breast neoplasm.